STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

UBX UNITY BIOTECHNOLOGY INCORPORATED StockScouter® Report

5

StockScouter® Score

UNITY BIOTECHNOLOGY INCORPORATED, a small cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The 50-day moving average for UBX is significantly above its 200-day moving average. Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 60% done.
Progress: 80% done.
Low
High

Core Model Grades

D
C
N/A
B

Previous Ratings

9
4